期刊文献+

内皮细胞乙酰胆碱靶标不同于M受体的药理学特征 被引量:11

Pharmacological characteristics of the endothelial-target for acetylcholine different from muscarinic receptors
下载PDF
导出
摘要 目的 研究内皮细胞乙酰胆碱靶标与M受体药理学特征的差异。方法 采用离体血管环实验方法,观察抗M_3受体的单克隆抗体和M受体激动剂毛果芸香碱对乙酰胆碱引起的内皮依赖性舒张血管作用的影响。结果 毛果芸香碱能够剂量依赖性拮抗乙酰胆碱诱导的内皮依赖性血管舒张作用,其拮抗性质为非竞争性拮抗;抗M_3受体的单克隆抗体不影响乙酰胆碱诱发的内皮依赖性舒张血管作用,但能拮抗乙酰胆碱诱发的离休肠肌收缩作用。结论 内皮细胞乙酰胆碱靶标的药理学特征不同于经典M受体。 AIM To examine whether the endo-thelial-target for acetylcholine is different from muscarinic receptors. METHODS By means of isometrictension test in isolated ring segment of artery derived from rat, we observed the effects of monoantibody against M3 receptors and pilocarpine on endothelium-dependent vascular relaxation induced by acetylcholine. RESULTS The endothelium-dependent vascular relaxation induced by acetylcholine could be blocked by pilocarpine in dose-dependent manner in isolated preparation derived from rat artery. The antagonism of pilocarpine was fit for noncompetitive characteristics; the endothe-lium-dependent vascular relaxation induced by ace-tylcholine could not be blocked by monoantibody a-gainst M3 receptors, but contraction tension induced by acetylcholine in isolated rat ileum could be blocked by monoantibody against M3 receptors. CONCLUTION The endothelial target for acetylcholine had the unique pharmacological characteristics different from those of muscarinic receptor.
出处 《中国药理学通报》 CAS CSCD 北大核心 2003年第6期660-664,共5页 Chinese Pharmacological Bulletin
基金 国家"973"重点基础研究发展规划项目 No G199805112 北京赛德维康医药研究院新药研究基金 No 1999001
关键词 抗M3受体单克隆抗体 毛果芸香碱 内皮细胞乙酰胆碱靶标 monoantibody against M3 recep-tors pilocarpine the endothelial-target for acetyl- choline
  • 相关文献

参考文献13

  • 1[1]Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature,1987;327(6122): 534~6
  • 2[2]Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension,1993;21(6Pt2) 929~33
  • 3[3]Katz SD, Schwarz M, Yuen J,LeJemtel TH. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors. Circulation, 1993;88(1):56~61
  • 4[4]Liao JK, Bettmann MA, Sandor T et al. Differential impairment of vasodilator responsivenes of peripheral resistance and conduit vessels in human with atherosclerosis. Circ Res,1991;68(4):1027~34
  • 5[5]Walch L, Brink L, Norel X. The muscarinic receptor subtypes in human blood vessels. Therapie, 2001; 56(3): 223~6
  • 6[6]Wu CC, Chen SJ, Yen MH. Loss of acetylcholine-induced relaxation by M3-receptor activation in mesenteric arteries of spontaneously hypertensive rats. J Cardiovase Pharmacol, 1997;30(20):245~52
  • 7[7]Jaiswal N, Lambrecht G, Mutschler E et al. Pharmacological characterization of the vascular muscarinic receptors mediating relaxation and contraction in rabbit aorta. J Pharmacol Exp Ther, 1991;258(3):842~50
  • 8[8]Shan LM, Wang H. Pharmacological characteristics of the endothelial target for acetylcholine induced vascular relaxation. Life Sci, 2002;70(11): 1285~98
  • 9[9]Zeng SJ, Li S, Peng DW et al. Preparation of monoclonal antibody against human m3 receptor. Acta Pharmacol Sin, 2000;21(4):335~9
  • 10[10]Manjeet S, Sim MK. Atropine- and scopolamine-resistant subtypes of muscarinic receptors in the rabbit aorta. Eur J Pharmacol, 1989;174(1):99~105.

同被引文献102

引证文献11

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部